FDA Releases Report On Drug Shortages

An analysis in the report found that two-thirds of 163 drugs in short supply in recent years were available as generics, generally at low cost.” The drugs “were older, too, on the market for a median of almost 35 years.” However, “quality-control problems at manufacturing facilities were responsible for more than half of recent drug shortages, the task force also found.” https://www.nytimes.com/2019/10/29/health/drug-shortages-generics.html